COMMUNIQUÉS West-GlobeNewswire

Obalon Therapeutics Announces Closing of $10 Million Private Placement

27/08/2018 - 15:02

SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]

Delcath Announces Acceptance of Abstract for Poster Presentation at CIRSE 2018

27/08/2018 - 15:00

NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces an abstract from a [...]

Naturally Splendid Increases Vertical Integration and Expands International Footprint -- CFN Media

27/08/2018 - 15:00

SEATTLE, Aug. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Lexington Announces Non-Brokered Private Placement

27/08/2018 - 15:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, Aug. 27, 2018 (GLOBE NEWSWIRE [...]

AXIM® Biotechnologies Enters Canadian Market Through New Exclusive Distribution and License Agreement With Revive Therapeutics

27/08/2018 - 15:00

AXIM Partners with REVIVE to Begin Selling Its Leading Cannabidiol-Containing Nutraceutical Product in Canada NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM® Biotech or the “Company” ) ( [...]

Scythian Biosciences Closes Acquisition of MMJ Colombia Partners

27/08/2018 - 14:50

Closing of Colombia Acquisition is Key Benchmark in Finalization of Previously Announced $193 Million Sale of Assets in Latin America, Which As Of Friday’s Close Was Valued At More than $219 Million TORONTO, Aug. 27, [...]

Solon Eiendom ASA – Primary insider notification

27/08/2018 - 14:45

(Oslo, Norway, 27 August 2018) Per Knut Asphaug Bernhardt, PA to the chairman of the board of Solon Eiendom ASA, has today rolled over two forward contracts for a total of 124,375 shares in Solon Eiendom ASA. Through [...]

Cannabix Technologies Provides Technology Update on Marijuana Breathalyzer Development

27/08/2018 - 14:45

The Cannabix Marijuana Breathalyzer is being developed to give law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. ( [...]

Novo Nordisk A/S - Share repurchase programme

27/08/2018 - 14:31

Bagsværd, Denmark, 27 August 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]

NRC Health Releases First Loyalty-Based U.S. Hospital Rankings

27/08/2018 - 14:30

Largest online consumer healthcare survey reveals top hospitals in consumer loyalty, according to more than 300,000 U.S. consumers LINCOLN, Neb., Aug. 27, 2018 (GLOBE NEWSWIRE) -- NRC Health , the leading provider of in [...]

BioCanCell Announces Company Name Change to Anchiano Therapeutics

27/08/2018 - 14:30

CAMBRIDGE, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE: ANCN), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today announced [...]

Assure Holdings to Present at the 7th Annual Liolios Gateway Conference on September 5, 2018

27/08/2018 - 14:30

DENVER, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has been invited to present at the 7 th Annual [...]

Rhinogram Announces Appointment of New President to Guide Expansion into Medical Practice Market

27/08/2018 - 14:30

Company also adds chief technology officer to drive company’s technology architecture CHATTANOOGA, Tenn., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Rhinogram , a leader in cloud-based, HIPAA-compliant, telehealth communications [...]

Intellia Therapeutics to Present at September Healthcare Investor Conferences

27/08/2018 - 14:00

CAMBRIDGE, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, will [...]

Tyme Technologies, Inc. to Present at the Rodman & Renshaw 20th Annual Global Investment Conference

27/08/2018 - 14:00

NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced that it will be featured as a [...]

Ceapro Inc. Settles Judgements in AVAC Ltd. Actions

27/08/2018 - 14:00

EDMONTON, Alberta, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V:CZO) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for [...]

Savara Becomes Inaugural Foundation Sponsor of the PAP Foundation

27/08/2018 - 14:00

Savara and the PAP Foundation Form Global Partnership Which Will Support and Unite the Community of Individuals Afflicted with Pulmonary Alveolar Proteinosis (PAP) AUSTIN, Texas and LOS ANGELES, Aug. 27, 2018 (GLOBE [...]

Aeglea BioTherapeutics to Present New Interim Phase 1/2 Clinical Trial Data in Arginase 1 Deficiency at 2018 SSIEM Annual Symposium

27/08/2018 - 14:00

Company to Host Clinical Update Conference Call on September 4 at 8:30 a.m. ET AUSTIN, Texas, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that [...]

Pediapharm Announces Q1 Results – Record Revenue and 12th Consecutive Year-Over-Year Quarterly Growth

27/08/2018 - 14:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Pediapharm Inc. (the “Company” or "Pediapharm") (TSX VENTURE: PDP) (OTCQB: PDDPF) is [...]